Spread of multiple SARS-CoV-2 lineages April-August 2020 anticipated the second pandemic wave in Lombardy (Italy).
COVID-19
NGS
SARS-CoV-2
molecular epidemiology
whole genome sequencing
Journal
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
ISSN: 1399-3038
Titre abrégé: Pediatr Allergy Immunol
Pays: England
ID NLM: 9106718
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
revised:
28
07
2021
received:
11
06
2021
accepted:
07
08
2021
entrez:
26
1
2022
pubmed:
27
1
2022
medline:
1
2
2022
Statut:
ppublish
Résumé
During the early phase of the pandemic (20 February-4 April 2020), we have investigated the temporal and geographical evolution of the virus in Lombardy showing the circulation of at least seven lineages distributed differently in the Region. In the present study, the molecular epidemiology of SARS-CoV-2 was monitored in a period between two pandemic waves in order to track the circulation of new variants (April-August 2020). A great majority of SARS-CoV-2 strains (70.8%) belonged to lineages B, B.1, B.1.1 and B.1.1.1, and five strains belonging to four lineages were already reported in Italy (B.1.1.148, B.1.1.162, B.1.1.71, and B.1.425). In addition, 21 SARS-CoV-2 strains belonged to six lineages not previously observed in Italy were detected. No variants of concern were observed. A total of 152/1274 (11.3%) amino acid changes were observed among spike gene sequences and only 26/152 (17.1%) occurred in the receptor-binding domain region of the spike protein. Results of this study are indicative of ongoing transmission throughout the lockdown period, rather than re-introduction of novel lineages past lockdown. The use of molecular epidemiology in Italy should be promoted in order to provide additional understanding of the transmission of the disease and to have major effect on controlling the spread of disease.
Identifiants
pubmed: 35080310
doi: 10.1111/pai.13641
pmc: PMC9542480
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
89-92Subventions
Organisme : European Union's Horizon 2020 Research and Innovation Programme
ID : 101003650
Organisme : "Ricerca Finalizzata" from Ministry of Health, Italy
ID : GR-2013-02358399
Organisme : "Ricerca Finalizzata" from Ministry of Health, Italy
ID : COVID-2020-12371817
Informations de copyright
© 2022 The Authors. Pediatric Allergy and Immunology published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
Références
Nat Commun. 2021 Jan 19;12(1):434
pubmed: 33469026
Viruses. 2020 Dec 14;12(12):
pubmed: 33327566
Pediatr Allergy Immunol. 2022 Jan;33 Suppl 27:89-92
pubmed: 35080310
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
Int J Infect Dis. 2021 Jan;102:299-302
pubmed: 33130202
Euro Surveill. 2020 Aug;25(32):
pubmed: 32794443
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508